108 related articles for article (PubMed ID: 6330393)
1. [Susceptibility of clinical isolates to cefotaxime. Comparison to new antibiotics latamoxef, cefoperazone, and ceftizoxime].
Asari S; Horikawa M; Tsukamoto H; Shimizu Y; Koda K; Hayashi C; Miyai K
Jpn J Antibiot; 1984 Feb; 37(2):267-78. PubMed ID: 6330393
[TBL] [Abstract][Full Text] [Related]
2. [Susceptibility of clinical isolates to cefotaxime].
Asari S; Horikawa M; Tsukamoto H; Hayashi C; Miyai K
Jpn J Antibiot; 1983 Feb; 36(2):277-89. PubMed ID: 6304369
[TBL] [Abstract][Full Text] [Related]
3. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T
Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
[TBL] [Abstract][Full Text] [Related]
4. [Susceptibility of clinical isolates to aztreonam].
Asari S; Horikawa M; Tsukamoto H; Kouda K; Hayashi C; Miyai K
Jpn J Antibiot; 1987 Jul; 40(7):1317-31. PubMed ID: 3479624
[TBL] [Abstract][Full Text] [Related]
5. Ceftizoxime (FK 749) in vitro antibacterial activity.
Husson MO; Courcol R; Izard D; Leclerc H
Infection; 1984; 12(1):40-5. PubMed ID: 6323320
[TBL] [Abstract][Full Text] [Related]
6. [Antibacterial activities of new cephems against clinically isolated organisms (author's transl)].
Okada K; Kawamura N; Ohkoshi M; Satake Y; Kawakita J
Jpn J Antibiot; 1982 Apr; 35(4):1009-21. PubMed ID: 6285019
[TBL] [Abstract][Full Text] [Related]
7. The serum bactericidal activity of latamoxef (moxalactam), cefoperazone and cefotaxime.
McNamee W; Drusano GL; Tatem BA; Standiford HC
J Antimicrob Chemother; 1984 Nov; 14(5):491-7. PubMed ID: 6096348
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of in vitro antibacterial activities of new cephems against clinical organisms (isolated between June 1983 and January 1984)].
Tsuji A; Goto S; Sato K; Tomizawa M; Hasebe S; Takagi T; Yatagai S; Kanno H; Ozaki K; Yakata M
Jpn J Antibiot; 1985 Aug; 38(8):2171-84. PubMed ID: 3908734
[TBL] [Abstract][Full Text] [Related]
9. In vitro antibacterial activity of ceftizoxime against gram-negative strains.
Debbia E; Soro O
Chemioterapia; 1985 Apr; 4(2):166-9. PubMed ID: 3891115
[TBL] [Abstract][Full Text] [Related]
10. [Sensitivity of the recent bacterial isolates to cefotaxime and other cephem antibiotics].
Fujita S; Yoshida T; Okado N; Matsubara F
Jpn J Antibiot; 1983 Oct; 36(10):2887-92. PubMed ID: 6325747
[TBL] [Abstract][Full Text] [Related]
11. [Antimicrobial activity of cefotiam against various clinical isolates from 1981 to 1985].
Matsuo K; Uete T
Jpn J Antibiot; 1986 Aug; 39(8):1981-7. PubMed ID: 3467078
[TBL] [Abstract][Full Text] [Related]
12. [Susceptibility of bacteria isolated from lower respiratory tract infections to antibiotics (1983)].
Ikemoto H; Watanabe K; Kosakai N; Hayashi Y; Oguri T; Saito A; Shinohara M; Matsumiya H; Ueda K; Ida S
Jpn J Antibiot; 1985 Nov; 38(11):3119-44. PubMed ID: 3937915
[TBL] [Abstract][Full Text] [Related]
13. Comparative activity of ceftizoxime against aminoglycoside-resistant aerobic gram-negative bacilli.
Gómez-Lus R; Rubio MC; García C; Gómez-Lus ML; Alejandre MC
Drugs Exp Clin Res; 1987; 13(3):155-9. PubMed ID: 3497792
[TBL] [Abstract][Full Text] [Related]
14. In vitro antibacterial activity of ceftizoxime.
Andreoni O; Andreoni S; Molinari GL; Farinetti F
Chemioterapia; 1985 Apr; 4(2):161-5. PubMed ID: 3859380
[TBL] [Abstract][Full Text] [Related]
15. [Susceptibility of recent clinical isolates of Pseudomonas aeruginosa and Serratia marcescens to cefotaxime, ceftizoxime, cefmenoxime, latamoxef and cefsulodin in comparison with other beta-lactam antibiotics and aminoglycosides].
Kawakami Y; Okimura Y; Horiuchi N; Kanai M
Jpn J Antibiot; 1982 Sep; 35(9):2314-7. PubMed ID: 6292543
[No Abstract] [Full Text] [Related]
16. In vitro antibacterial activity and beta-lactamase stability of cefodizime, a new cephalosporin antibiotic.
Kasai K; Tsuji A; Miyazaki S; Goto S; Fujimoto K; Masuyoshi S; Arai S
Jpn J Antibiot; 1984 Jul; 37(7):1294-305. PubMed ID: 6092739
[TBL] [Abstract][Full Text] [Related]
17. [Fundamental and clinical evaluation of ceftriaxone in the pediatric field].
Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
Jpn J Antibiot; 1984 Nov; 37(11):2111-30. PubMed ID: 6098705
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.
Shibl AM; Ishag AH; Durgham SM
Chemotherapy; 1989; 35 Suppl 1():72-6. PubMed ID: 2659292
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of in vitro activity of first, second and third generation cephem antibiotics against various pathogens isolated from clinical materials in 1983].
Matsuo K; Tsuzaki Y; Furukawa S; Uete T
Jpn J Antibiot; 1984 Jun; 37(6):1040-57. PubMed ID: 6387213
[TBL] [Abstract][Full Text] [Related]
20. [Resistance of Enterobacteria to cefotaxime and lamoxactam at the Pitié-Salpêtrière Hospital in 1982].
Nicolas MH; Jarlier V; Fievet MH; Nguyen J; Truffot C
Pathol Biol (Paris); 1984 May; 32(5):393-5. PubMed ID: 6330650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
